TCI Wealth Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

TCI Wealth Advisors’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$982	–	1287
2023 Q1	$982	Hold	10	–	–	﹤0.01%	2111
2022 Q4	$1.41K	Sell	10 -4	-29%	-$558	﹤0.01%	2045
2022 Q3	$2K	Hold	14	–	–	﹤0.01%	1951
2022 Q2	$2K	Buy	14 +9	+180%	+$1.53K	﹤0.01%	2008
2022 Q1	$2K	Buy	5 +4	+400%	+$1.51K	﹤0.01%	1995
2021 Q4	$1K	Buy	+1	New	+$957	﹤0.01%	2210
2020 Q2	–	Sell	-5	Closed	-$2K	–	1569
2020 Q1	$2K	Buy	+5	New	+$4.55K	﹤0.01%	1027
2016 Q3	–	Sell	-1	Closed	-$1K	–	1382
2016 Q2	$1K	Hold	1	–	–	﹤0.01%	1092
2016 Q1	$1K	Buy	+1	New	+$633	﹤0.01%	1100
2015 Q4	–	Sell	-1	Closed	-$1K	–	1056
2015 Q3	$1K	Buy	+1	New	+$3.05K	﹤0.01%	896

Other funds holding LABU

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Gainplan Bloomfield Hills, Michigan $254M AUM 25.62% 1-Year Est. Return

TCI Wealth Advisors's LABU Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2023, closing a stake of 10 shares — an estimated $982 sold.

TCI Wealth Advisors first reported a position in LABU in Q3 2015 and held it in 10 quarters. The position peaked at $2K in Q3 2022. 51 funds tracked by Wall St. Rank hold LABU as of Q2 2023.

TCI Wealth Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2023, an estimated $982.
TCI Wealth Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and held it in 10 quarters.
TCI Wealth Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $2K in Q3 2022.
51 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.